News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Emrullah Yilmaz: Excited to join the amivantamab clinical team at Johnson and Johnson Innovative Medicine
Photo and logo of Emrullah Yilmaz from LinkedIn
Jun 25, 2024, 16:15

Emrullah Yilmaz: Excited to join the amivantamab clinical team at Johnson and Johnson Innovative Medicine

Emrullah Yilmaz, Medical Director at Johnson & Johnson Innovative Medicine, shared on LinkedIn:

“I’m happy to share that I’m starting a new position as Medical Director, Clinical Development at Johnson & Johnson Innovative Medicine!

Excited to join the amivantamab clinical team!”

Source: Emrullah Yilmaz/LinkedIn

Amivantamab cancer Emrullah Yilmaz Johnson & Johnson Innovative Medicine OncoDaily Oncology
Special Coverage
Opinion
Nov 13, 2024, 10:32
The 6th Biennial Miami Epigenetics and Cancer Symposium to be held in Sylvester Comprehensive Cancer Center
Blog
Nov 13, 2024, 10:16
Highlights from IU Simon Comprehensive Cancer Center’s End Lung Cancer Now Gathering - Hoosier Cancer Research Network
Blog
Nov 13, 2024, 10:06
A first-in-class Antibody Drug Conjugate that works by directly stimulating the immune system
Blog
Nov 13, 2024, 09:55
Moderna Incorporation announced the awardees of its 2024 Australia Fellowship Program
Blog
Nov 13, 2024, 09:39
AI tools to improve diagnosis and therapy in neuro-oncology
Insight
Nov 13, 2024, 09:27
Nikki Rossetti et al. on Early-Stage Lung Cancer in the Era of Lung Cancer Screening
Blog
Nov 13, 2024, 09:14
Yüksel Ürün: Key takeaways on high-risk and locally advanced prostate cancer from António Rui Azevedo Freitas
Blog
Nov 13, 2024, 09:11
Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy
Blog
Nov 13, 2024, 09:09
Yüksel Ürün: Not all that shines is Prostate cancer – a striking reminder from Daniela Oprea-Lager
Blog
Nov 13, 2024, 09:01
Updated Results with Mitazalimab as a first-line treatment for advance pancreatic cancer
Blog
Nov 13, 2024, 08:59
Miriam Mutebi: What To Expect During A Mammogram
Insight
Nov 13, 2024, 08:56
Rachel Riechelmann: Low dose Everolimus for patients with Neuroendocrine tumors